Natco Pharma Ltd
NSE:NATCOPHARM
Natco Pharma Ltd
NSE:NATCOPHARM
Price:
1 087.05
INR
-0.41%
Market Closed
Market Cap:
₹194.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Natco Pharma Ltd
NSE:NATCOPHARM
|
IN |
|
Itway SpA
MIL:ITW
|
IT |
|
Advanced Drainage Systems Inc
NYSE:WMS
|
US |
|
G
|
Gr Sarantis SA
ATHEX:SAR
|
GR |
|
D
|
DigiCo Infrastructure REIT
ASX:DGT
|
AU |
|
O
|
Origin Energy Ltd
F:ORL
|
AU |
|
Atlantic American Corp
NASDAQ:AAME
|
US |
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
|
CNB Financial Corp
NASDAQ:CCNE
|
US |
|
Maisons du Monde SA
PAR:MDM
|
FR |
|
Blue Biofuels Inc
OTC:BIOF
|
US |
|
P
|
Perpetual Energy Inc
TSX:PMT
|
CA |
|
First Niles Financial Inc
OTC:FNFI
|
US |
|
Gryphon Digital Mining Inc
NASDAQ:ABTC
|
US |
|
China Aviation Oil (Singapore) Corporation Ltd
SGX:G92
|
SG |
|
C
|
Cosmos Holdings Inc
NASDAQ:COSM
|
US |
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
UK |
|
Accelerated Technologies Holding Corp
OTC:ATHC
|
US |
|
Rosseti Severo-Zapad PAO
MOEX:MRKZ
|
RU |
|
N
|
Northview Acquisition Corp
NASDAQ:NVAC
|
US |
|
First Hotel Co Ltd
TWSE:2706
|
TW |
|
Harford Bank
OTC:HFBK
|
US |
|
O
|
Ottakringer Getraenke AG
VSE:OTV
|
AT |
|
I
|
Incannex Healthcare Ltd
NASDAQ:IXHL
|
AU |
Multiples-Based Value
The
Multiples-Based Value for
Natco Pharma Ltd (NATCOPHARM)
under the Base Case is
hidden
INR.
Compared with the current market price of 1 087.05 INR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NATCOPHARM Multiples-Based Value
LOCKED
Multiples Across Competitors
NATCOPHARM Competitors Multiples
Natco Pharma Ltd Competitors
Natco Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Natco Pharma Ltd
NSE:NATCOPHARM
|
195.5B INR | 4.3 | 12.5 | 8.4 | 9.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
854.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.8B USD | 5.9 | 26.8 | 17.2 | 22 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.5B GBP | 5.2 | 29.8 | 16.5 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.2 | 12.5 | 16.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.7B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.1 | 8.2 | 9.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.5B GBP | 2.6 | 15.1 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
